期刊文献+

阿托伐他汀对进展性脑梗死进展时间及神经功能的影响 被引量:1

下载PDF
导出
摘要 目的探讨阿托伐他汀对进展性脑梗死进展时间及神经功能缺损程度的影响。方法选取2007-10~2010-05我院神经内科住院的进展性脑梗死患者120例,随机分为治疗组和对照组各60例,对照组采用阿司匹林肠溶片抗血小板治疗,应用脑保护剂,尼莫地平降颅压,以及常规内科综合治疗。治疗组在对照组治疗基础上加用阿托伐他汀片20 mg/d,睡前服用,连用4周。观察入院时、进展停止时、发病4周时神经功能缺损程度和发病至症状达高峰时间及治疗前后血脂变化。结果阿托伐他汀可以缩短发病至症状达峰时间,在发病4周时NIHSS评分方面与对照组相比差异有统计学意义。结论进展性脑梗死早期应用阿托伐他汀可降低血脂水平和改善预后。
作者 张启田
出处 《中国实用神经疾病杂志》 2011年第12期41-42,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献5

二级参考文献31

共引文献61

同被引文献15

  • 1Raddino R, Della Pina P, Gorga E, et al. Indications for statin ther- apy in patients with acute coronary syndrome of ischemic origin [ J]. G Ital Cardiol(Rome) ,2010,11 ( 10 Suppl 1 ) :78S-83S.
  • 2Kim GB, Kim JK, Park S, et al. Effect of atorvastatin and elopi- dogrel co-administration after coronary stenting in korean patients with stable angina [ J ]. Korean Circ J, 2011,41 ( 1 ) : 28-33.
  • 3Hamdan R, Hajj F, Kadry Z, et al. Benefit and tolerability of the coadministration of ezetimibe and atorvastatin in acute coronary syndrome patients[ J]. J Med Liban,2011,59(2) :65-69.
  • 4Prakash P, Khanna V, Singh V, et al. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats[ J. Cardiovasc Drugs Ther,2011,25 (4) : 285-297.
  • 5Wilson SR, Sabatine MS, Wiviott SD, et al. Assessment of adipone- ctin and the risk of recurrent cardiovascular events in patients pres- enting with an acute coronary syndrome: observations from the pravastatin or atorvastatin evaluation and infection trial-thrombolys- is in myocardial infarction 22( PROVE IT-TIMI 22) [ J. Am Heart J,2011,161 (6) :1147-1155.
  • 6Fukushima Y, Hirayama S, Ueno T,et al. Small dense LDL choles- terol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome [ J ]. Clin Chim Acta,2011,412(15/16) :1423-1427.
  • 7Patti G, Ricottini E, Nusca A, et al. Short-term, high-dose atorvas- tatin pretreatment to prevent contrast-induced . phropathy in pa- tients with acute coronary syndromes undergoing percutaneous coro- nary intervention ( from the ARMYDA-CIN [ atorvastatin for reduc- tion of myocardial damage during angioplasty-contrast-induced ne- phropathy ] trial J ]. Am J Cardio1,2011,108 ( 1 ) : 1-7.
  • 8Truong QA, Murphy SA, Mccabe CH,et al. Benefit of intensive sta- tin therapy in women : results from PROVE IT-TIMI 22 [ J ]. Circ Cardiovasc Qual Outcomes,2011,4 (3) :328-336.
  • 9Nesar Hossein V, Yosef Nejad K, Abdollahian F. Short-term thera- py with high dose atorvastatin in patients with coronary artery dis- ease can reduce inflammatory process[ J]. Acta Med Iran ,2010,48 (4) :218-221.
  • 10李文霞.阿托伐他汀对冠心病伴高脂血症患者血脂的影响[J].河北医药,2011,33(12):1825-1826. 被引量:15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部